Eli Lilly previously said that phase three study was expected to finish in February 2026 ... Lilly's weight loss shot Zepbound and diabetes drug Mounjaro, mimics two of the hormones, GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback